• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

验证和确认系统性红斑狼疮症状清单患者生活质量的日本版。

Validation and verification of the Japanese version of the systemic lupus erythematosus symptom checklist for patient quality of life.

机构信息

Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Department of the Advanced Medicine for Rheumatic Diseases, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

出版信息

Lupus. 2021 Jun;30(7):1108-1115. doi: 10.1177/09612033211005026. Epub 2021 Mar 28.

DOI:10.1177/09612033211005026
PMID:33779381
Abstract

OBJECTIVE

The systemic lupus erythematosus (SLE) symptom checklist (SSC) is a patient-reported outcome measure consisting of 38 queries. We translated SSC into Japanese and attempted to validate its usefulness for evaluating the quality of life (QOL) of SLE patients and identify factors that affect QOL.

METHODS

Data from the Medical Outcomes Study Short-form 36 questionnaire (SF-36), Japanese LupusPRO, the Japanese version of the SSC (SSC-J) questionnaire, SLEDAI-2k, and the physician global assessment (PGA) were obtained on the same day from 226 SLE outpatients of the Kyoto Lupus cohort at Kyoto University Hospital. Relationships between the total scores or each item of SSC-J and SF-36, Japanese LupusPRO, SLEDAI-2k, or PGA were analyzed by Spearman's rank test.

RESULTS

The total scores of SSC-J correlated with the scores of SF-36 and Japanese LupusPRO. In each item of SSC-J, all 38 items correlated with the physical component summary and mental component summary of SF-36 as well as the Health-Related QOL (HRQOL) scores of Japanese LupusPRO, but not with the non-HRQOL of LupusPRO. SSC-J scores correlated with age, PGA, and corticosteroid doses, but not with SLEDAI-2k.

CONCLUSIONS

SSC-J is suitable as a disease-specific QOL assessment tool for SLE.

摘要

目的

系统性红斑狼疮(SLE)症状清单(SSC)是一种包含 38 个问题的患者报告结局测量工具。我们将 SSC 翻译成日语,并尝试验证其用于评估 SLE 患者生活质量(QOL)和识别影响 QOL 的因素的有用性。

方法

从京都大学医院的京都狼疮队列的 226 名 SLE 门诊患者同一天获得了医疗结局研究短表 36 项问卷(SF-36)、日本 LupusPRO、SSC-J 问卷的日语版、SLEDAI-2k 和医生整体评估(PGA)的数据。通过 Spearman 秩检验分析 SSC-J 的总分或每个项目与 SF-36、日本 LupusPRO、SLEDAI-2k 或 PGA 之间的关系。

结果

SSC-J 的总分与 SF-36 和日本 LupusPRO 的得分相关。在 SSC-J 的每个项目中,38 个项目都与 SF-36 的生理成分综合和心理成分综合以及日本 LupusPRO 的健康相关生活质量(HRQOL)评分相关,但与 LupusPRO 的非 HRQOL 不相关。SSC-J 评分与年龄、PGA 和皮质类固醇剂量相关,但与 SLEDAI-2k 无关。

结论

SSC-J 适合作为 SLE 的特定疾病 QOL 评估工具。

相似文献

1
Validation and verification of the Japanese version of the systemic lupus erythematosus symptom checklist for patient quality of life.验证和确认系统性红斑狼疮症状清单患者生活质量的日本版。
Lupus. 2021 Jun;30(7):1108-1115. doi: 10.1177/09612033211005026. Epub 2021 Mar 28.
2
Validation of the LupusPRO version 1.8: an update to a disease-specific patient-reported outcome tool for systemic lupus erythematosus.LupusPRO 1.8版的验证:系统性红斑狼疮特定疾病患者报告结局工具的更新
Lupus. 2018 Apr;27(5):728-737. doi: 10.1177/0961203317739128. Epub 2017 Oct 31.
3
The Arabic LupusPRO: A Cross-Cultural Validation of a Disease-Specific Patient-Reported Outcome Tool for Quality of Life in Lupus Patients.阿拉伯文狼疮患者报告结局工具(LupusPRO):一种用于评估狼疮患者生活质量的跨文化验证的疾病特异性患者报告结局工具。
Lupus. 2020 Nov;29(13):1727-1735. doi: 10.1177/0961203320953482. Epub 2020 Sep 2.
4
Turkish lupusPRO: cross-cultural validation study for lupus.土耳其狼疮PRO:狼疮的跨文化验证研究。
Clin Rheumatol. 2014 Aug;33(8):1079-84. doi: 10.1007/s10067-013-2345-9. Epub 2013 Aug 11.
5
Factors affecting discrepancies in disease activity evaluation between patients and physicians in systemic lupus erythematosus-The importance of symptoms such as fatigue.系统性红斑狼疮患者与医生之间疾病活动度评估差异的影响因素——疲劳等症状的重要性
Lupus. 2024 Oct;33(12):1336-1344. doi: 10.1177/09612033241281909. Epub 2024 Sep 14.
6
Comparisons of SLE-DAS and SLEDAI-2K and classification of disease activity based on the SLE-DAS with reference to patient-reported outcomes.SLE-DAS 与 SLEDAI-2K 的比较及基于 SLE-DAS 与患者报告结局参照的疾病活动分类。
Rheumatology (Oxford). 2023 Dec 1;62(12):3909-3915. doi: 10.1093/rheumatology/kead132.
7
Correlation between irreversible organ damage and the quality of life of patients with systemic lupus erythematosus: The Kyoto Lupus Cohort survey.系统性红斑狼疮患者不可逆性器官损伤与生活质量的相关性:京都狼疮队列研究。
Lupus. 2021 Sep;30(10):1577-1585. doi: 10.1177/09612033211025614. Epub 2021 Jun 14.
8
Hindi LupusPRO: cross cultural validation of disease specific patient reported outcome measure of lupus.印地语狼疮患者报告结局测量:疾病特异性患者报告结局测量的跨文化验证。
Lupus. 2019 Nov;28(13):1534-1540. doi: 10.1177/0961203319880340. Epub 2019 Oct 21.
9
Cross-cultural validation of a disease-specific patient-reported outcome measure for systemic lupus erythematosus in Canada.在加拿大对一种用于系统性红斑狼疮的疾病特异性患者报告结局测量工具进行跨文化验证。
J Rheumatol. 2013 Aug;40(8):1327-33. doi: 10.3899/jrheum.121129. Epub 2013 Jun 15.
10
Sex Differences in Quality of Life in Patients With Systemic Lupus Erythematosus.系统性红斑狼疮患者生活质量的性别差异。
Arthritis Care Res (Hoboken). 2019 Dec;71(12):1647-1652. doi: 10.1002/acr.23588. Epub 2018 Dec 20.

引用本文的文献

1
The Association of Anti-dsDNA Antibodies with Patient-reported Outcomes of Patients with Systemic Lupus Erythematosus in a Two-consecutive Year Prospective Study.一项为期两年的前瞻性研究:抗双链DNA抗体与系统性红斑狼疮患者自我报告结局的关联
Kobe J Med Sci. 2025 Feb 3;70(4):E113-E124. doi: 10.24546/0100492949.
2
Memory B cells and their transcriptomic profiles associated with belimumab resistance in systemic lupus erythematosus in the maintenance phase.维持期系统性红斑狼疮中与贝利尤单抗耐药相关的记忆B细胞及其转录组图谱。
Front Immunol. 2025 Feb 5;16:1506298. doi: 10.3389/fimmu.2025.1506298. eCollection 2025.
3
Promoting awareness of terminology related to unmet medical needs in context of rheumatic diseases in Japan: a systematic review for evaluating unmet medical needs.
在日本风湿性疾病背景下促进与未满足医疗需求相关术语的认知:评估未满足医疗需求的系统评价。
Rheumatol Int. 2023 Nov;43(11):2021-2030. doi: 10.1007/s00296-023-05425-z. Epub 2023 Aug 19.
4
Medium-term impact of the SARS-CoV-2 mRNA vaccine against disease activity in patients with systemic lupus erythematosus.SARS-CoV-2 mRNA 疫苗对系统性红斑狼疮患者疾病活动度的中期影响。
Lupus Sci Med. 2022 Aug;9(1). doi: 10.1136/lupus-2022-000727.